 Following screening, a 4-week period of single blind treatment with nabilone 0.5 - 4 mgday flexible dosing will take place. All subjects will begin with nabilone therapy of 1 mg daily for a minimum of 4 days, with the dose of the study medication assessed and adjusted either upwards or downwards as needed to balance efficacy for pain control with tolerability for possible side effects. 